Author: admin

Genentech will acquire Regor’s next-generation CDK inhibitors for an upfront payment of $850 million in cash. Regor is also eligible to receive additional cash payments contingent on achieving future development, regulatory and commercial milestones CAMBRIDGE, Mass., Sept. 30, 2024 /PRNewswir

With collaboration from Cohere, Fujitsu promotes the utilization of generative AI by achieving advanced customization in a secure private environment News Facts: Fujitsu launches Takane, a Japanese-language large language model (LLM) designed for secure enterprise use Integrated into Fujitsu’s

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: